LXGTF — Lexington Biosciences Holdings Balance Sheet
0.000.00%
Last trade - 00:00- $0.00m
- $0.00m
Annual balance sheet for Lexington Biosciences Holdings, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.013 | 0.028 | 0.001 | 0 | — |
| Total Current Assets | 0.013 | 0.028 | 0.001 | 0 | — |
| Other Long Term Assets | |||||
| Total Assets | 0.013 | 0.028 | 0.001 | 0 | 0 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.05 | 1.52 | 1.82 | 0.811 | 0.989 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 1.05 | 1.52 | 1.82 | 0.811 | 0.989 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -1.04 | -1.49 | -1.82 | -0.811 | -0.989 |
| Total Liabilities & Shareholders' Equity | 0.013 | 0.028 | 0.001 | 0 | 0 |
| Total Common Shares Outstanding |